Exploring 3 Undervalued Small Caps In Global With Insider Activity

In This Article:

In recent weeks, global markets have shown resilience, with U.S. small-cap indexes advancing for the fourth consecutive week amid easing trade tensions and better-than-expected earnings reports. Despite a mixed economic backdrop with contracting GDP and cooling job openings, investor sentiment remains buoyant, particularly in the small-cap space where growth potential often intersects with market optimism. In this environment, identifying promising small-cap stocks involves looking for companies that demonstrate robust fundamentals and strategic insider activity—signals that can indicate confidence in their future prospects even amidst broader economic uncertainties.

Top 10 Undervalued Small Caps With Insider Buying Globally

Name

PE

PS

Discount to Fair Value

Value Rating

Tristel

28.4x

4.0x

24.32%

★★★★★★

Propel Holdings

17.7x

1.8x

34.76%

★★★★★☆

Nexus Industrial REIT

5.3x

2.7x

24.07%

★★★★★☆

Chorus Aviation

NA

0.4x

16.36%

★★★★★☆

Savaria

26.2x

1.5x

42.48%

★★★★☆☆

Savills

24.5x

0.5x

42.10%

★★★★☆☆

Sing Investments & Finance

7.0x

3.6x

44.05%

★★★★☆☆

FRP Advisory Group

12.8x

2.3x

13.47%

★★★☆☆☆

Italmobiliare

11.4x

1.5x

-275.29%

★★★☆☆☆

Arendals Fossekompani

NA

1.6x

42.97%

★★★☆☆☆

Click here to see the full list of 156 stocks from our Undervalued Global Small Caps With Insider Buying screener.

We're going to check out a few of the best picks from our screener tool.

Integral Diagnostics

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Integral Diagnostics operates diagnostic imaging facilities, providing medical imaging services across Australia and New Zealand, with a market cap of approximately A$1.06 billion.

Operations: Integral Diagnostics generates revenue primarily from its diagnostic imaging facilities, with a recent revenue figure of A$491.32 million. The company's gross profit margin shows a downward trend, reaching 31.66% as of the latest period. Operating expenses, including general and administrative costs, are significant components impacting net income margins, which have been volatile recently.

PE: 157.1x

Integral Diagnostics, a diagnostic imaging company, has recently caught the eye of private equity firms after its market value dipped to A$837 million following half-year results. Despite reporting a net loss of A$0.396 million for the period ending December 2024, insider confidence is evident with James Hall purchasing 36,000 shares valued at approximately A$78,840 between February and March 2025. The company's earnings are anticipated to grow by over 40% annually, suggesting potential for future growth in the healthcare sector.